83 FR 60900 - Importer of Controlled Substances Application: Fisher Clinical Services, Inc.
DEPARTMENT OF JUSTICE
Drug Enforcement Administration Federal Register Volume 83, Issue 228 (November 27, 2018)
Drug Enforcement Administration
Federal Register Volume 83, Issue 228 (November 27, 2018)
| Page Range | 60900-60900 | |
| FR Document | 2018-25872 |
[Federal Register Volume 83, Number 228 (Tuesday, November 27, 2018)] [Notices] [Page 60900] From the Federal Register Online [www.thefederalregister.org] [FR Doc No: 2018-25872] ----------------------------------------------------------------------- DEPARTMENT OF JUSTICE Drug Enforcement Administration [Docket No. DEA-392] Importer of Controlled Substances Application: Fisher Clinical Services, Inc. ACTION: Notice of application. ----------------------------------------------------------------------- DATES: Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 27, 2018. Such persons may also file a written request for a hearing on the application on or before December 27, 2018. ADDRESSES: Written comments should be sent to: Drug Enforcement Administration, Attention: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing must be sent to: Drug Enforcement Administration, Attn: Administrator, 8701 Morrissette Drive, Springfield, Virginia 22152. All requests for hearing should also be sent to: (1) Drug Enforcement Administration, Attn: Hearing Clerk/OALJ, 8701 Morrissette Drive, Springfield, Virginia 22152; and (2) Drug Enforcement Administration, Attn: DEA Federal Register Representative/DPW, 8701 Morrissette Drive, Springfield, Virginia 22152. SUPPLEMENTARY INFORMATION: The Attorney General has delegated his authority under the Controlled Substances Act to the Administrator of the Drug Enforcement Administration (DEA), 28 CFR 0.100(b). Authority to exercise all necessary functions with respect to the promulgation and implementation of 21 CFR part 1301, incident to the registration of manufacturers, distributors, dispensers, importers, and exporters of controlled substances (other than final orders in connection with suspension, denial, or revocation of registration) has been redelegated to the Assistant Administrator of the DEA Diversion Control Division (``Assistant Administrator'') pursuant to section 7 of 28 CFR part 0, appendix to subpart R. In accordance with 21 CFR 1301.34(a), this is notice that on September 27, 2018, Fisher Clinical Services, Inc., 700A-C Nestle Way, Breinigsville, Pennsylvania 18031, has applied to be registered as an importer of the below listed basic classes of controlled substances listed in schedule I & II. ------------------------------------------------------------------------ Controlled substance Drug code Schedule ------------------------------------------------------------------------ Psilocybin.............................. 7437 I Methylphenidate......................... 1724 II Levorphanol............................. 9220 II Noroxymorphone.......................... 9668 II Tapentadol.............................. 9780 II ------------------------------------------------------------------------ The company plans to import the listed controlled substances for analytical research, testing, and clinical trials. This authorization does not extend to the import of a finished FDA approved or non- approved dosage form for commercial distribution in the United States. Dated: November 16, 2018. John J. Martin, Assistant Administrator. [FR Doc. 2018-25872 Filed 11-26-18; 8:45 am] BILLING CODE 4410-09-P
![60900 Federal Register / Vol. 83, No. 228 / Tuesday, November 27, 2018 / Notices
The company plans to manufacture applicants therefore, may file written authority under the Controlled
bulk synthetic active pharmaceutical comments on or objections to the Substances Act to the Administrator of
ingredients (APIs) for product issuance of the proposed registration on the Drug Enforcement Administration
development and distribution to its or before December 27, 2018. Such (DEA), 28 CFR 0.100(b). Authority to
customers. No other activity for these persons may also file a written request exercise all necessary functions with
drug codes are authorized for this for a hearing on the application on or respect to the promulgation and
registration. before December 27, 2018. implementation of 21 CFR part 1301,
Dated: November 16, 2018. ADDRESSES: Written comments should incident to the registration of
John J. Martin, be sent to: Drug Enforcement manufacturers, distributors, dispensers,
Administration, Attention: DEA Federal importers, and exporters of controlled
Assistant Administrator.
Register Representative/DPW, 8701 substances (other than final orders in
[FR Doc. 2018–25862 Filed 11–26–18; 8:45 am]
Morrissette Drive, Springfield, Virginia connection with suspension, denial, or
BILLING CODE 4410–09–P revocation of registration) has been
22152. All requests for hearing must be
sent to: Drug Enforcement redelegated to the Assistant
Administration, Attn: Administrator, Administrator of the DEA Diversion
DEPARTMENT OF JUSTICE
8701 Morrissette Drive, Springfield, Control Division (‘‘Assistant
Drug Enforcement Administration Virginia 22152. All requests for hearing Administrator’’) pursuant to section 7 of
should also be sent to: (1) Drug 28 CFR part 0, appendix to subpart R.
[Docket No. DEA–392] Enforcement Administration, Attn: In accordance with 21 CFR
Importer of Controlled Substances Hearing Clerk/OALJ, 8701 Morrissette 1301.34(a), this is notice that on
Application: Fisher Clinical Services, Drive, Springfield, Virginia 22152; and September 27, 2018, Fisher Clinical
Inc. (2) Drug Enforcement Administration, Services, Inc., 700A–C Nestle Way,
Attn: DEA Federal Register Breinigsville, Pennsylvania 18031, has
ACTION: Notice of application. Representative/DPW, 8701 Morrissette applied to be registered as an importer
Drive, Springfield, Virginia 22152. of the below listed basic classes of
DATES: Registered bulk manufacturers of SUPPLEMENTARY INFORMATION: The controlled substances listed in schedule
the affected basic classes, and Attorney General has delegated his I & II.
Controlled substance Drug code Schedule
Psilocybin ................................................................................................................................................................. 7437 I
Methylphenidate ....................................................................................................................................................... 1724 II
Levorphanol ............................................................................................................................................................. 9220 II
Noroxymorphone ..................................................................................................................................................... 9668 II
Tapentadol ............................................................................................................................................................... 9780 II
The company plans to import the DEPARTMENT OF JUSTICE authority under the Controlled
listed controlled substances for Substances Act to the Administrator of
analytical research, testing, and clinical Drug Enforcement Administration the Drug Enforcement Administration
trials. This authorization does not [Docket No. DEA–392] (DEA), 28 CFR 0.100(b). Authority to
extend to the import of a finished FDA exercise all necessary functions with
approved or non-approved dosage form Bulk Manufacturer of Controlled respect to the promulgation and
for commercial distribution in the Substances Application: Cayman implementation of 21 CFR part 1301,
United States. Chemical Company incident to the registration of
manufacturers, distributors, dispensers,
Dated: November 16, 2018. ACTION: Notice of application. importers, and exporters of controlled
John J. Martin, substances (other than final orders in
Assistant Administrator. DATES: Registered bulk manufacturers of connection with suspension, denial, or
the affected basic classes, and revocation of registration) has been
[FR Doc. 2018–25872 Filed 11–26–18; 8:45 am]
applicants therefore, may file written redelegated to the Assistant
BILLING CODE 4410–09–P comments on or objections to the Administrator of the DEA Diversion
issuance of the proposed registration on Control Division (‘‘Assistant
or before January 28, 2019. Administrator’’) pursuant to section 7 of
ADDRESSES: Written comments should 28 CFR part 0, appendix to subpart R.
be sent to: Drug Enforcement In accordance with 21 CFR
Administration, Attention: DEA Federal 1301.33(a), this is notice that on July 25,
Register Representative/DPW, 8701 2018, Cayman Chemical Company, 1180
Morrissette Drive, Springfield, Virginia East Ellsworth Road, Ann Arbor,
22152. Michigan 48108 applied to be registered
SUPPLEMENTARY INFORMATION: The as a bulk manufacturer for the basic
amozie on DSK3GDR082PROD with NOTICES1
Attorney General has delegated his classes of controlled substances:
Controlled substance Drug code Schedule
3-Fluoro-N-methylcathinone (3–FMC) ....................................................................................................................... 1233 I
Cathinone ................................................................................................................................................................... 1235 I
Methcathinone ............................................................................................................................................................ 1237 I
4-Fluoro-N-methylcathinone (4–FMC) ....................................................................................................................... 1238 I
VerDate Sep<11>2014 17:45 Nov 26, 2018 Jkt 247001 PO 00000 Frm 00080 Fmt 4703 Sfmt 4703 E:\FR\FM\27NON1.SGM 27NON1](https://thefederalregister.org/doc/83_FR_61128/page/1.svg)
Document Created: 2018-11-27 01:25:09
Document Modified: 2018-11-27 01:25:09
| Category | Regulatory Information | |
| Collection | Federal Register | |
| sudoc Class | AE 2.7: GS 4.107: AE 2.106: | |
| Publisher | Office of the Federal Register, National Archives and Records Administration | |
| Section | Notices | |
| Action | Notice of application. | |
| Dates | Registered bulk manufacturers of the affected basic classes, and applicants therefore, may file written comments on or objections to the issuance of the proposed registration on or before December 27, 2018. Such persons may also file a written request for a hearing on the application on or before December 27, 2018. | |
| FR Citation | 83 FR 60900 |
2024 Federal Register | Disclaimer | Privacy Policy
USC | CFR | eCFR